Blau syndrome (familial granulomatous arthritis, iritis, and rash) was orig
inally described in 1985, in 11 members of a family of Dutch ancestry. Inhe
ritance is autosomal dominant. Several more Caucasian families have been de
scribed since. Skin and synovial biopsy specimens show noncaseating sarcoid
like granulomas, but the lung is not involved as in classic sarcoidosis. T
his report describes 3 members of an African American family with Blau synd
rome. It is important to differentiate this genetic disorder from other chi
ldhood arthritides, such as, juvenile rheumatoid arthritis, juvenile spondy
loarthropathies, and early-onset sarcoidosis, because of the need for genet
ic counseling, treatment and differing potential for selective involvement
of other organs (eye, skin, and tendons/joints). All children of an affecte
d individual have a 50% chance of inheriting the disease. Unaffected childr
en do not have to be concerned about subsequent generations being affected.
The response to conventional treatments used in juvenile rheumatoid arthrit
is and to etanercept in our patients has not been satisfactory. Joint disea
se responds to corticosteroids, but these agents are not suitable for a dis
ease that is lifelong. The eye involvement is aggressive and can lead to bl
indness. These patients need close follow-up by an ophthalmologist.